We are live on ! Find out more
OH

Oikos Holdings Portfolio holdings

AUM $422M
1-Year Est. Return 13.79%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+13.79%
3 Year Est. Return
+5.54%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33.2M
AUM Growth
-$11M
Cap. Flow
-$13.2M
Cap. Flow %
-39.61%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 37.47%
2 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLOT icon
1
iShares Floating Rate Bond ETF
FLOT
$10B
$20.8M 62.53%
408,254
– –
FG
2
DELISTED
FGL Holdings Ordinary Shares
FG
$12.5M 37.47%
1,582,500
– –
MLNT
3
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
– –
-3,321,592
Closed -$13.2M

Similar funds

VFPI
Vantage Financial Partners (Illinois) Arlington Heights, Illinois $402M AUM 12.97% 1-Year Est. Return
LWMG
Levy Wealth Management Group Philadelphia, Pennsylvania $391M AUM 14.68% 1-Year Est. Return
TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return
CU
CQS (US) New York $367M AUM 8.85% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
GH
Geisinger Health Danville, Pennsylvania $344M AUM 4.22% 1-Year Est. Return

Oikos Holdings's Q1 2019 Portfolio in Review

As of Q1 2019, Oikos Holdings held 3 positions worth $33.2M, down 25% from $44.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Oikos Holdings withdrew a net $13.2M in Q1 2019, closing 1 position. Its most notable exit was Melinta Therapeutics, Inc. Common Stock, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 24% a quarter earlier, followed by Healthcare.

  • Oikos Holdings fully exited Melinta Therapeutics, Inc. Common Stock in Q1 2019, selling an estimated $13.2M.
  • Oikos Holdings's ten largest holdings make up 100% of its $33.2M portfolio in Q1 2019.
  • Oikos Holdings opened 0 new positions and closed 1 in Q1 2019.
  • Oikos Holdings's portfolio value fell 25% quarter-over-quarter to $33.2M.

Based on Oikos Holdings's 13F filing for Q1 2019, filed 13 May 2019.